SNSE earnings: a negative outcome, -5.4%

On August 9, 2022, Sensei Biotherapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.4% in the window around the event. It had already run -11.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.